CP and neoplasm: DiR-loaded, Cy5.5-labeled PCL-CP NPs at an optimal N/P/S/S ratio of 10:1:1:0.5 showed high and concentrated signals in tumors for both DiR and Cy5.5 compared to other major organs, indicating that PCL-CP NPs were stable in blood and highly effective in tumor targeting (Fig. 4a).